En bref: Vertex, Sandoz, Naobios, Pfizer

2023-12-15 15:00:00

Vertex signs licensing agreement with Editas Medicine

Vertex has just signed a licensing agreement with the American biotech Editas Medicine for its Cas9 gene editing technology, CRISPR scissors. This agreement includes Casgevy (exagamglogene autotemcel), a cell therapy from Vertex approved in early December by the FDA against sickle cell disease. Thanks to this agreement, which according to several media could reach $100 million (€91 million), Editas Medicine’s cash flow is extended until 2026.

Sandoz begins its Slovenian project

The laboratory specializing in generic and biosimilar medicines, now independent, announced that it has started the construction of its new factory in Lendava, Slovenia. The result of an investment of 400 million euros, the installation will include three buildings, dedicated to the manufacture of organic products. Their cumulative surface area will reach 40,000 m2, with commissioning scheduled for the end of 2026.


Naobios receives €1.7 million

The Nantes CDMO specializing in vaccines received financial aid of 1.87 million dollars (1.7 million euros) from the Bill & Melinda Gates Foundation. Thanks to this amount, Naobios wants to develop and produce an HVCA (Human viral challenge agent) of the Omicron variant of SARS-CoV-2, to accelerate the development of vaccines. The vaccine in question is intended to be administered into the mucous membranes and will be intended for low- and middle-income countries.

Pfizer completes Seagen transaction

After the green light from the Federal Trade Commission (FTC), Pfizer has finalized the $43 billion purchase of the American biotech company Seagan. The operation was definitively concluded on December 14, after being announced last March. Seagen develops and commercializes compounds positioned in oncology, particularly antibody-drug conjugates (ADCs). For 2024, Pfizer expects biotech products to generate $3.1 billion in sales.

Selected for you

En bref : Pharnext, Lilly, National Resilience

#bref #Vertex #Sandoz #Naobios #Pfizer

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.